Published in Proc Soc Exp Biol Med on June 01, 1967
Anti-serum to cultured human lymphoblasts: preparation, purification and immunosuppressive properties in man. Ann Surg (1969) 1.37
Improvements in the preparation of heterologous antilymphocyte globulin with special reference to absorption and diethylaminoethyl cellulose batch production. Surgery (1969) 1.29
Induction and suppression of the cytotoxic activity of human lymphocytes in vitro by heterologous anti-lymphocyte serum. Clin Exp Immunol (1969) 1.06
Analysis of the biological activity of antilymphocyte serum. 3. Concentration of immunosuppressive activity in one IgG subfraction and its inhibition by another. Immunology (1971) 0.95
Recurrent thyrotoxicosis after subtotal thyroidectomy. Br Med J (1971) 0.93
Immunity to Escherichia coli in pigs: IgG immunoglobulin in passive immunity to E. coli enteritis. Immunology (1973) 0.89
Depression of grass pollen-induced lymphocyte transformation by serum from hyposensitized patients. Clin Exp Immunol (1975) 0.87
Inhibition of plaque formation, rosette formation and phagocytosis by alpha globulin. Immunology (1972) 0.83
Prolonged survival of skin allografts in rats treated with heterologous anti-skin serum. Clin Exp Immunol (1970) 0.80
The immunogenic components of equine anti-human lymphocyte lobulin in renal allograft recipients. Clin Exp Immunol (1972) 0.77
The importance of the included serum proteins in the immune response in rabbits to a rat skin xenograft. Am J Pathol (1973) 0.75
Treatment of the severely burned child with skin transplantation modified by immunosuppressive therapy. Ann Surg (1974) 0.75
Comparison of in vitro effects of anti-skin serum with anti lymphocyte serum. Clin Exp Immunol (1973) 0.75
Purification of lymphocytes and platelets by gradient centrifugation. J Lab Clin Med (1968) 4.02
Handedness, language lateralisation and anatomical asymmetry in schizophrenia: meta-analysis. Br J Psychiatry (2001) 2.74
Pancreatico-duodenal allotransplantation: experimental and clinical experience. Ann Surg (1970) 2.44
Epstein-Barr virus-induced B-cell lymphoma after renal transplantation: acyclovir therapy and transition from polyclonal to monoclonal B-cell proliferation. N Engl J Med (1982) 2.44
The impact of cyclosporine and combination immunosuppression on the incidence of posttransplant diabetes in renal allograft recipients. Transplantation (1987) 2.40
Increasing physician productivity and the hospitalization characteristics of practices using Medex. A progress report. Northwest Med (1971) 2.34
Effects of pancreatic transplantation on diabetic neuropathy. N Engl J Med (1990) 2.32
Immunologic and nonimmunologic factors: different risks for cadaver and living donor transplantation. Transplantation (2000) 2.25
Clinical spectrum of lymphoproliferative disorders in renal transplant recipients and evidence for the role of Epstein-Barr virus. Cancer Res (1981) 2.25
Orthotopic liver transplantation: a pathological study of 63 serial liver biopsies from 17 patients with special reference to the diagnostic features and natural history of rejection. Hepatology (1985) 2.18
Transplantation of discordant xenografts: a review of progress. Immunol Today (1990) 2.00
Risk factors for chronic rejection in renal allograft recipients. Transplantation (1993) 1.90
Lessons learned from more than 1,000 pancreas transplants at a single institution. Ann Surg (2001) 1.89
Cytomegalovirus-induced immune suppression. I. Humoral immunity. Clin Exp Immunol (1974) 1.86
Association of renal allograft rejection with virus infections. Am J Med (1974) 1.83
Vascular graft thrombosis after pancreatic transplantation: univariate and multivariate operative and nonoperative risk factor analysis. J Am Coll Surg (1996) 1.83
Increased incidence of malignancy during chronic renal failure. Lancet (1975) 1.79
Recurrence of idiopathic nephrotic syndrome after renal transplantation. Lancet (1972) 1.71
Hepatocellular transplantation for metabolic deficiencies: decrease of plasms bilirubin in Gunn rats. Science (1976) 1.65
Delayed graft function, acute rejection, and outcome after cadaver renal transplantation. The multivariate analysis. Transplantation (1995) 1.65
Progression of diabetic retinopathy after pancreas transplantation for insulin-dependent diabetes mellitus. N Engl J Med (1988) 1.65
Hepatic resection for secondary neoplasms. Surgery (1982) 1.64
Complications and risks of living donor nephrectomy. Transplantation (1997) 1.61
The impact of an acute rejection episode on long-term renal allograft survival (t1/2). Transplantation (1994) 1.58
Cytomegalovirus-induced immune suppression. II. Cell-mediated immunity. Clin Exp Immunol (1974) 1.55
Phagocytic release and activation of human leukocyte procollagenase. Nature (1973) 1.55
Effects of hemipancreatectomy on insulin secretion and glucose tolerance in healthy humans. N Engl J Med (1990) 1.53
The Epstein-Barr virus in the pathogenesis of posttransplant lymphoproliferative disorders. Clinical, pathologic, and virologic correlation. Surgery (1981) 1.53
Colon perforation after renal transplantation: a single-institution review. Clin Transplant (1997) 1.47
Clinical characteristics of the lethal cytomegalovirus infection following renal transplantation. Surgery (1977) 1.45
The correlation of MLC with graft survival. Transplant Proc (1973) 1.44
Fractionated total lymphoid irradiation as preparative immunosuppression in high risk renal transplantation: clinical and immunological studies. Ann Surg (1982) 1.44
A ten year experience with cadaver kidney preservation using cryoprecipitated plasma. Am J Surg (1978) 1.44
Circadian variation in the rejection of rat kidney allografts. Surgery (1973) 1.43
Steroid diabetes in renal transplant recipients: pathogenetic factors and prognosis. Surgery (1973) 1.43
Intra-abdominal infections in pancreas transplant recipients. Ann Surg (1986) 1.42
Systemic fat embolism after renal homotransplantation and treatment with corticosteroids. N Engl J Med (1965) 1.42
2,500 living donor kidney transplants: a single-center experience. Ann Surg (2001) 1.41
Hyperglycemic nonketotic coma after liver transplantation. Arch Surg (1972) 1.40
The glomerular mesangium. 3. Acute immune mesangial injury: a new model of glomerulonephritis. J Exp Med (1973) 1.40
Uremic pericardial effusion. Treatment by catheter drainage and local nonabsorbable steroid administration. Nephron (1976) 1.39
Infection and rejection of primary hepatic transplant in 93 consecutive patients treated with triple immunosuppressive therapy. Surg Gynecol Obstet (1988) 1.38
Anti-serum to cultured human lymphoblasts: preparation, purification and immunosuppressive properties in man. Ann Surg (1969) 1.37
Autologous islet transplantation to prevent diabetes after pancreatic resection. Ann Surg (1995) 1.37
Cyclosporin A in renal transplantation: a prospective randomized trial. Surgery (1982) 1.36
Cure of dysgerminoma with widespread metastases appearing after renal transplantation. N Engl J Med (1970) 1.36
Correlation between MLC stimulation and graft survival in living related and cadaver transplants. Ann Surg (1974) 1.36
The effects of pancreas transplantation on the glomerular structure of renal allografts in patients with insulin-dependent diabetes. N Engl J Med (1989) 1.35
Protection of the donor kidney during homotransplantation. Ann Surg (1966) 1.34
Cytomegalovirus: Clinical virological correlations in renal transplant recipients. Ann Surg (1974) 1.34
Total or near total pancreatectomy and islet autotransplantation for treatment of chronic pancreatitis. Ann Surg (1980) 1.34
Synergistic effects on DNA synthesis of phytohemagglutinin or concanavalin A and lipopolysaccharide in human peripheral blood lymphocytes. J Immunol (1975) 1.32
Liver allograft rejection. An analysis of the use of biopsy in determining outcome of rejection. Am J Surg Pathol (1987) 1.30
Human islet autotransplantation following pancreatectomy. Transplant Proc (1979) 1.30
Prevention of urological complications after kidney transplantation. Ann Surg (1971) 1.29
Pancreatic islet cell transplantation. Surg Clin North Am (1978) 1.28
Renal transplantation in high-risk patients. Arch Surg (1971) 1.28
Seven years' experience with antilymphoblast globulin for renal transplantation from cadaver donors. Ann Surg (1976) 1.26
Renal transplantation in children ages 1 to 5 years. Pediatrics (1978) 1.25
Improved patient survival in renal transplantation. Surgery (1976) 1.25
The clinical use of antilymphocyte globulin. N Engl J Med (1971) 1.24
Role of virus infections in immunosuppressed renal transplant patients. Transplant Proc (1973) 1.23
Differences in rejection grading after simultaneous pancreas and kidney transplantation in pigs. Transplantation (1994) 1.22
Mycotic aneurysms in transplant patients. Arch Surg (1976) 1.21
Development of diabetic vascular lesions in normal kidneys transplanted into patients with diabetes mellitus. N Engl J Med (1976) 1.21
Short- and long-term outcomes of kidney transplants with multiple renal arteries. Ann Surg (1995) 1.21
Experimental renal heterotransplantation. I. In widely divergent species. Transplantation (1966) 1.20
One hundred pancreas transplants at a single institution. Ann Surg (1984) 1.20
Effect of initial slow graft function on renal allograft rejection and survival. Clin Transplant (1997) 1.19
Quantitative glomerular morphology of the normal human kidney. Lab Invest (1983) 1.18
Human islet transplantation: a preliminary report. Transplant Proc (1977) 1.18
Breakdown of noncollagenous chondromucoprotein matrix by leukocyte lysosome granule lysates from guinea pig, rabbit, and human. Clin Immunol Immunopathol (1973) 1.18
Acute fulminant Wegener granulomatosis. Therapy with immunosuppression, hemodialysis, and renal transplantation. Arch Intern Med (1974) 1.18
Is HL-A typing of clinical significance in cadaver renal transplantation? Lancet (1974) 1.17
Morphology of cyclosporine nephrotoxicity and acute rejection in patients immunosuppressed with cyclosporine and prednisone. Surgery (1983) 1.16
A new subcutaneous arteriovenous shunt: applicable in cases where the standard Quinton-Scribner shunt and arteriovenous fistula have failed. Surgery (1973) 1.16
The treatment of chronic uremia in childhood. I. Transplantation. Pediatrics (1970) 1.16
Separation of anti-inflammatory and immunosuppressive activities in heterologous antilymphocyte serum. Nature (1969) 1.16
Aspergillosis in 25 renal transplant patients. Epidemiology, clinical presentation, diagnosis, and management. Ann Surg (1983) 1.15
The bleeding cecal ulcer: pathogenesis, angiographic diagnosis, and nonoperative control. Surgery (1972) 1.15
A single institution, randomized, prospective trial of cyclosporin versus azathioprine-antilymphocyte globulin for immunosuppression in renal allograft recipients. Ann Surg (1985) 1.15
Pulmonary complications in transplant recipients. Arch Surg (1972) 1.15
Mechanisms of kidney allograft rejection. Transplant Proc (1969) 1.14
100 second renal allografts from a single transplantation institution. Transplantation (1979) 1.14
Macrophage-T cell interactions in the Con A induction of human suppressive T cells. J Immunol (1978) 1.14
Pseudorejection: factors mimicking rejection in renal allograft recipients. Ann Surg (1977) 1.13
Correction of enzymatic deficiencies by renal transplantation: Fabry's disease. Surgery (1972) 1.13
Symptomatic depression in elderly medical outpatients. I. Prevalence, demography, and health service utilization. J Am Geriatr Soc (1986) 1.13
Hepatocellular transplantation in acute liver failure. Surgery (1977) 1.12
Renal transplantation in patients over 50 years of age. Transplant Proc (1981) 1.12
Evolution of kidney, pancreas, and islet transplantation for patients with diabetes at the University of Minnesota. Am J Surg (1993) 1.12
The effect of pancreas transplantation on diabetic polyneuropathy. Transplantation (1988) 1.12
Pancreas transplantation. Surg Clin North Am (1986) 1.12
Ketoconazole, cyclosporin metabolism, and renal transplantation. Lancet (1982) 1.12
Living-related donor segmental pancreatectomy for transplantation. Transplant Proc (1980) 1.11
Insulin independence in type I diabetes after transplantation of unpurified islets from single donor with 15-deoxyspergualin. Lancet (1993) 1.11
Cytotoxic antibodies following human renal transplantation. Surg Forum (1969) 1.11
Autotransplantation of dispersed pancreatic islet tissue combined with total or near-total pancreatectomy for treatment of chronic pancreatitis. Surgery (1991) 1.10